PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Boixadera, Anna
TI  - Long-Term Ranibizumab Effective in Diabetic Macular Edema
DP  - 2013 Dec 01
TA  - MD Conference Express
PG  - 13--13
VI  - 13
IP  - 17
4099  - http://mdc.sagepub.com/content/13/17/13.1.short
4100  - http://mdc.sagepub.com/content/13/17/13.1.full
AB  - In patients with diabetic macular edema, long-term intravitreal injections of ranibizumab maintains best-corrected visual acuity and central retinal subfield thickness improvements over 36 months, with no new or increased safety concerns. This article discusses the final analysis of the 36-month study comprising: A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-Label Extension Study [RESTORE; NCT00687804].